ACTIVATE trial generated positive safety and efficacy data for mitapivat. — ScienceDaily
Researchers have published the results of a clinical trial that led the U.S. Food and Drug Administration to recently approve mitapivat for the treatment of adults with pyruvate kinase deficiency…
